FORT SMITH, Ark. - ArcBest (NASDAQ:ARCB), a logistics and transportation company with a 22-year track record of consistent ...
The global robotic surgery market is growing rapidly, driven by technological advancements, particularly in artificial ...
Citi lowered the firm’s price target on Merck (MRK) to $125 from $130 and keeps a Buy rating on the shares. Ahead of the Q4 earnings, the firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback